XARACOLL® (bupivacaine HCl) delivers postsurgical analgesia for up to 24 hours following open inguinal hernia repair in adults

PAIN RELIEF RIGHT AT THE SOURCE

XARACOLL® is the FIRST and ONLY implant to deliver immediate and long‑lasting postsurgical analgesia for up to 24 hours following open inguinal hernia repair in adults.

XARACOLL is a fully resorbable and biodegradable collagen implant containing the local anesthetic bupivacaine. XARACOLL was developed to be easily implanted during the time of surgery directly at the source of pain to provide significant pain relief while minimizing or eliminating the use of opioids.


POSIMIR® (bupivacaine solution) provides up to 72 hours of non-opioid pain relief following arthroscopic subacromial decompression

UP TO 72 HOURS OF RELIABLE PAIN RELIEF

POSIMIR® is the FIRST and ONLY locally administered, single-site bupivacaine injection, providing significant pain relief up to 72 hours following arthroscopic subacromial decompression.

POSIMIR is a ready-to-use bupivacaine solution that provides consistent and sustained delivery of local analgesia offering patients up to 3 days of pain relief while minimizing or eliminating the use of opioids.

Promoting Portfolio of Ethicon Hernia Mesh and Fixation Products

NEW INDICATIONS ON THE HORIZON

There’s much more to come. Here’s a preview of how we’re planning to expand our
portfolio to support hospitals in impacting patient outcomes.

The Innocoll pipeline includes XARACOLL®, POSIMIR®, and preclinical programs in oncology and immunology
Leveraging CollaRx technology for potential opportunities in oncology and immunology
The Innocoll pipeline includes XARACOLL®, POSIMIR®, and preclinical programs in oncology and immunology
Leveraging CollaRx technology for potential opportunities in oncology and immunology